Vermilion Life Sciences Ltd
Stuart is Chair of the Advisory Committee on Clinical Excellence Awards (ACCEA). He is a fully GMC registered physician, who trained in General Medicine and General Practice before gaining many years’ experience in senior leadership roles at Roche, GlaxoSmithKline, Norgine, Takeda and UCB. He is the Founder of Vermilion Life Sciences, which provides consultancy services to reduce the time and cost of medicines development to improve patient access.
Stuart is also an Authority Member of the Human Tissue Authority, a Board Trustee of the Faculty of Pharmaceutical Medicine, and has worked as an external ‘Champion'' for the UK Government''s Office for Life Sciences, Accelerated Access Review.
Reengineering Medicines Development
Exploring opportunities to reduce the cost and time of medicines development. How patient input, digital tools and real world data in real time can facilitate adaptive licensing and early regulator and payer discussions to generate early access.
EVEN MORE SEMINARS
Sam Janes UCL
Early Detection of Lung Cancer
Dr Tom Newsom-Davis Leaders in Oncology Care (Part of HCA healthcare UK)
Immunotherapy and innovative systemic treatments in Oncology
Glenn Flux Royal Marsden Hospital
The emergence and resurgence of radiotherapeutics for cancer treatment
Professor of Experimental Medicine
Chris Curtis The Swallows Head & Neck Cancer Charity
A patient’s journey ‘Cancer to the palace in 6yrs’